Skip to main content

Peer Review reports

From: Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

Original Submission
8 Mar 2021 Submitted Original manuscript
24 May 2021 Reviewed Reviewer Report - Alexander Gough
26 May 2021 Reviewed Reviewer Report - Michael J. Grayling
9 Jul 2021 Author responded Author comments - Lorenzo Guglielmetti
Resubmission - Version 2
9 Jul 2021 Submitted Manuscript version 2
17 Jul 2021 Reviewed Reviewer Report - Alexander Gough
23 Jul 2021 Reviewed Reviewer Report - Michael J. Grayling
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Jul 2021 Editorially accepted
25 Sep 2021 Article published 10.1186/s13063-021-05491-3

You can find further information about peer review here.

Back to article page